vs

Side-by-side financial comparison of INVO Fertility, Inc. (IVF) and Tenon Medical, Inc. (TNON). Click either name above to swap in a different company.

INVO Fertility, Inc. is the larger business by last-quarter revenue ($1.8M vs $1.5M, roughly 1.2× Tenon Medical, Inc.). INVO Fertility, Inc. runs the higher net margin — -150.5% vs -191.2%, a 40.7% gap on every dollar of revenue. On growth, Tenon Medical, Inc. posted the faster year-over-year revenue change (92.3% vs 22.6%). Over the past eight quarters, Tenon Medical, Inc.'s revenue compounded faster (43.5% CAGR vs 12.8%).

INVO Fertility, Inc. is a specialized healthcare company focused on delivering accessible assisted reproductive technology solutions. It develops, manufactures and markets the patented INVOcell intravaginal culture system for in vitro fertilization procedures, serving fertility clinics and patients across North America, Europe and other global regions, with a mission to reduce barriers to high-quality fertility care.

Tenon Medical, Inc. is a specialized medical device company engaged in the R&D, production and commercialization of innovative orthopedic products including surgical instruments and implant systems, with core focus on the spinal surgery and minimally invasive musculoskeletal treatment segments, primarily serving healthcare markets in the U.S. and Europe.

IVF vs TNON — Head-to-Head

Bigger by revenue
IVF
IVF
1.2× larger
IVF
$1.8M
$1.5M
TNON
Growing faster (revenue YoY)
TNON
TNON
+69.7% gap
TNON
92.3%
22.6%
IVF
Higher net margin
IVF
IVF
40.7% more per $
IVF
-150.5%
-191.2%
TNON
Faster 2-yr revenue CAGR
TNON
TNON
Annualised
TNON
43.5%
12.8%
IVF

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
IVF
IVF
TNON
TNON
Revenue
$1.8M
$1.5M
Net Profit
$-2.6M
$-2.8M
Gross Margin
68.7%
Operating Margin
-93.1%
-193.5%
Net Margin
-150.5%
-191.2%
Revenue YoY
22.6%
92.3%
Net Profit YoY
-62.2%
8.3%
EPS (diluted)
$-0.77
$0.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IVF
IVF
TNON
TNON
Q4 25
$1.5M
Q3 25
$1.8M
$1.2M
Q2 25
$1.9M
$564.0K
Q1 25
$1.6M
$726.0K
Q4 24
$1.7M
$770.0K
Q3 24
$1.4M
$887.0K
Q2 24
$1.8M
$901.0K
Q1 24
$1.6M
$719.0K
Net Profit
IVF
IVF
TNON
TNON
Q4 25
$-2.8M
Q3 25
$-2.6M
$-3.3M
Q2 25
$-5.3M
$-2.8M
Q1 25
$-17.4M
$-3.6M
Q4 24
$-3.6M
$-3.1M
Q3 24
$-1.6M
$-3.2M
Q2 24
$-2.2M
$-3.8M
Q1 24
$-1.6M
$-3.6M
Gross Margin
IVF
IVF
TNON
TNON
Q4 25
68.7%
Q3 25
65.9%
Q2 25
43.4%
Q1 25
35.2%
44.5%
Q4 24
41.4%
45.8%
Q3 24
31.0%
47.1%
Q2 24
53.1%
52.2%
Q1 24
45.3%
65.4%
Operating Margin
IVF
IVF
TNON
TNON
Q4 25
-193.5%
Q3 25
-93.1%
-289.2%
Q2 25
-160.4%
-506.6%
Q1 25
-1042.1%
-506.5%
Q4 24
-202.0%
-412.1%
Q3 24
-90.7%
-362.5%
Q2 24
-100.9%
-429.7%
Q1 24
-95.7%
-487.6%
Net Margin
IVF
IVF
TNON
TNON
Q4 25
-191.2%
Q3 25
-150.5%
-284.7%
Q2 25
-283.6%
-491.0%
Q1 25
-1060.1%
-498.1%
Q4 24
-211.3%
-400.9%
Q3 24
-113.8%
-359.0%
Q2 24
-122.2%
-424.6%
Q1 24
-101.3%
-497.4%
EPS (diluted)
IVF
IVF
TNON
TNON
Q4 25
$0.07
Q3 25
$-0.77
$-0.40
Q2 25
$-13.30
$-0.36
Q1 25
$-12.53
$-1.01
Q4 24
$14.86
$10.55
Q3 24
$-15.11
$-3.63
Q2 24
$-22.39
$-8.16
Q1 24
$-7.55
$-10.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IVF
IVF
TNON
TNON
Cash + ST InvestmentsLiquidity on hand
$3.8M
Total DebtLower is stronger
$2.0M
Stockholders' EquityBook value
$5.8M
$5.0M
Total Assets
$18.8M
$10.8M
Debt / EquityLower = less leverage
0.34×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IVF
IVF
TNON
TNON
Q4 25
$3.8M
Q3 25
$3.4M
Q2 25
$7.8M
Q1 25
$10.3M
Q4 24
$6.5M
Q3 24
$9.2M
Q2 24
$2.0M
Q1 24
$4.4M
Total Debt
IVF
IVF
TNON
TNON
Q4 25
Q3 25
$2.0M
Q2 25
$4.8M
Q1 25
Q4 24
$7.5M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
IVF
IVF
TNON
TNON
Q4 25
$5.0M
Q3 25
$5.8M
$4.8M
Q2 25
$2.6M
$6.7M
Q1 25
$3.3M
$9.4M
Q4 24
$12.7M
$6.0M
Q3 24
$-23.3K
$8.2M
Q2 24
$1.4M
$832.0K
Q1 24
$10.2K
$3.6M
Total Assets
IVF
IVF
TNON
TNON
Q4 25
$10.8M
Q3 25
$18.8M
$10.4M
Q2 25
$19.3M
$11.1M
Q1 25
$31.7M
$13.4M
Q4 24
$46.4M
$9.8M
Q3 24
$17.0M
$13.0M
Q2 24
$17.8M
$6.0M
Q1 24
$17.3M
$8.0M
Debt / Equity
IVF
IVF
TNON
TNON
Q4 25
Q3 25
0.34×
Q2 25
1.83×
Q1 25
Q4 24
0.59×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IVF
IVF
TNON
TNON
Operating Cash FlowLast quarter
$-1.8M
$-2.2M
Free Cash FlowOCF − Capex
$-1.8M
FCF MarginFCF / Revenue
-101.6%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-7.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IVF
IVF
TNON
TNON
Q4 25
$-2.2M
Q3 25
$-1.8M
$-3.8M
Q2 25
$-1.7M
$-2.2M
Q1 25
$-3.5M
$-2.5M
Q4 24
$-617.4K
$-2.8M
Q3 24
$-640.8K
$-2.3M
Q2 24
$-1.5M
$-2.4M
Q1 24
$-260.6K
$-2.3M
Free Cash Flow
IVF
IVF
TNON
TNON
Q4 25
Q3 25
$-1.8M
$-3.9M
Q2 25
$-1.7M
Q1 25
$-3.6M
Q4 24
$-696.3K
$-2.8M
Q3 24
$-2.4M
Q2 24
$-1.5M
Q1 24
$-310.3K
$-2.5M
FCF Margin
IVF
IVF
TNON
TNON
Q4 25
Q3 25
-101.6%
-335.5%
Q2 25
-92.6%
Q1 25
-216.9%
Q4 24
-40.6%
-365.5%
Q3 24
-275.9%
Q2 24
-82.3%
Q1 24
-19.7%
-341.7%
Capex Intensity
IVF
IVF
TNON
TNON
Q4 25
Q3 25
0.5%
9.5%
Q2 25
0.5%
Q1 25
0.9%
Q4 24
4.6%
4.8%
Q3 24
0.0%
11.7%
Q2 24
3.0%
0.0%
Q1 24
3.2%
16.6%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons